SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-019846
Filing Date
2021-02-10
Accepted
2021-02-10 16:31:36
Documents
54
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm214780d1_10q.htm 10-Q 542501
2 EXHIBIT 31.1 tm214780d1_ex31-1.htm EX-31.1 13799
3 EXHIBIT 32.1 tm214780d1_ex32-1.htm EX-32.1 5280
  Complete submission text file 0001104659-21-019846.txt   3955124

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rzlt-20201231.xml EX-101.INS 857279
5 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20201231.xsd EX-101.SCH 41391
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rzlt-20201231_cal.xml EX-101.CAL 35901
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rzlt-20201231_def.xml EX-101.DEF 112891
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20201231_lab.xml EX-101.LAB 296193
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20201231_pre.xml EX-101.PRE 254968
Mailing Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065
Business Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065 650-847-1919
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39683 | Film No.: 21614341
SIC: 2834 Pharmaceutical Preparations